Elite Pharmaceuticals Inc. (OTCMKTS:ELTP – Get Free Report)’s stock price passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.36 and traded as high as $0.3997. Elite Pharmaceuticals shares last traded at $0.3990, with a volume of 1,049,725 shares trading hands.
Elite Pharmaceuticals Trading Up 6.4%
The stock has a market capitalization of $429.80 million, a PE ratio of 19.96 and a beta of 0.39. The firm has a 50-day moving average price of $0.36 and a 200-day moving average price of $0.39. The company has a current ratio of 6.45, a quick ratio of 5.22 and a debt-to-equity ratio of 0.04.
About Elite Pharmaceuticals
Elite Pharmaceuticals, Inc is a U.S.-based specialty pharmaceutical company that acquires, develops and markets both branded and generic pharmaceutical products. Headquartered in Houston, Texas, the company focuses on complex dosage forms—including injectables, sterile formulations and oncology therapies—and seeks to address unmet medical needs through advanced drug delivery technologies. Its product portfolio spans therapeutic areas such as pain management, oncology and cardiovascular care.
Since its founding in 2007, Elite Pharmaceuticals has pursued strategic partnerships and licensing agreements to expand its pipeline and manufacturing capabilities.
Recommended Stories
- Five stocks we like better than Elite Pharmaceuticals
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
